SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001214659-13-006503
Filing Date
2013-11-14
Accepted
2013-11-14 16:13:27
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2013 c11413210q.htm 10-Q 1076965
8 EXHIBIT 31.1 ex31_1.htm EX-31.1 14789
9 EXHIBIT 31.2 ex31_2.htm EX-31.2 15090
10 EXHIBIT 32.1 ex32_1.htm EX-32.1 6720
11 EXHIBIT 32.2 ex32_2.htm EX-32.2 6767
  Complete submission text file 0001214659-13-006503.txt   5764752

Data Files

Seq Description Document Type Size
2 EXHIBIT 101.INS anth-20130930.xml EX-101.INS 824424
3 EXHIBIT 101.SCH anth-20130930.xsd EX-101.SCH 42560
4 EXHIBIT 101.CAL anth-20130930_cal.xml EX-101.CAL 41693
5 EXHIBIT 101.DEF anth-20130930_def.xml EX-101.DEF 127751
6 EXHIBIT 101.LAB anth-20130930_lab.xml EX-101.LAB 629092
7 EXHIBIT 101.LAB anth-20130930_pre.xml EX-101.PRE 262666
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Filer) CIK: 0001316175 (see all company filings)

IRS No.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34637 | Film No.: 131220061
SIC: 2834 Pharmaceutical Preparations